Ticker League

Total Liabilities for Bristol-Myers Squibb (BMY)

As of · Reported

Metric

Latest period

$66.37B

YoY change

-6.1%

5Y CAGR

-2.4%

Peak year (2020)

$80.60B

Total Liabilities history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025

Latest: $71.53B

Total Liabilities growth chart for Bristol-Myers Squibb (BMY) from 1987 to 2025

Latest: -6.1%

Total Liabilities history table for Bristol-Myers Squibb (BMY) from 1987 to 2025

  • 2025$71.53B-6.1%
  • 2024$76.22B+16.1%
  • 2023$65.67B-0.0%
  • 2022$65.70B-10.4%
  • 2021$73.31B-9.0%
  • 2020$80.60B+3.0%
  • 2019$78.25B+275.1%
  • 2018$20.86B-3.9%
  • 2017$21.70B+25.0%
  • 2016$17.36B+0.2%
  • 2015$17.32B-7.7%
  • 2014$18.77B-19.7%
  • 2013$23.36B+4.9%
  • 2012$22.26B+30.1%
  • 2011$17.10B+10.8%
  • 2010$15.44B-4.8%
  • 2009$16.22B-6.1%
  • 2008$17.28B+10.7%
  • 2007$15.61B+0.2%
  • 2006$15.58B-8.0%
  • 2005$16.93B-16.3%
  • 2004$20.23B+14.6%
  • 2003$17.66B+8.6%
  • 2002$16.27B-13.2%
  • 2001$18.74B+123.1%
  • 2000$8.40B-0.8%
  • 1999$8.47B-2.6%
  • 1998$8.70B+12.1%
  • 1997$7.76B-4.4%
  • 1996$8.12B+0.1%
  • 1995$8.11B+12.5%
  • 1994$7.21B+17.0%
  • 1993$6.16B+28.8%
  • 1992$4.78B+32.1%
  • 1991$3.62B-4.6%
  • 1990$3.80B+11.3%
  • 1989$3.41B+2.6%
  • 1988$3.33B+20.5%
  • 1987$2.76B—

Total Liabilities values are taken from Bristol-Myers Squibb's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Total Liabilities at Bristol-Myers Squibb (BMY)

According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported total liabilities is $66.37B. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

In 2025, Bristol-Myers Squibb (BMY) total liabilities totalled $71.53B – declined 6.1% year-over-year.

Over 2020–2025 (5 years), Bristol-Myers Squibb total liabilities expanded at a -2.4% compound annual rate, with a net decline across the window.

The record annual total liabilities stands at $80.60B, reached in 2020; the historical low of $2.76B was recorded in 1987.

Bristol-Myers Squibb Total Liabilities by Year

Bristol-Myers Squibb Total Liabilities 2025: $71.53B

In 2025, Bristol-Myers Squibb reported total liabilities of $71.53B, declined 6.1% below 2024.

Bristol-Myers Squibb Total Liabilities 2024: $76.22B

Bristol-Myers Squibb total liabilities in 2024 was $76.22B, grew 16.1% from 2023.

Bristol-Myers Squibb Total Liabilities 2023: $65.67B

2023's total liabilities for Bristol-Myers Squibb came in at $65.67B, edged down 0.0% below 2022.

Bristol-Myers Squibb Total Liabilities 2022: $65.70B

Bristol-Myers Squibb posted total liabilities of $65.70B in 2022, declined 10.4% below 2021.

Bristol-Myers Squibb Total Liabilities 2021: $73.31B

Bristol-Myers Squibb total liabilities in 2021 was $73.31B.

See more financial history for Bristol-Myers Squibb (BMY).

Sector peers by Total Liabilities

Healthcare peers of Bristol-Myers Squibb (BMY), ranked by their latest total liabilities

Frequently asked questions

Bristol-Myers Squibb (BMY) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview